By Daniel Shortt, Attorney @ Harris Bricken This is the first post in a two-part series. Last week, the Food and Drug Administration (FDA) submitted a CBD enforcement policy to the White House. We do not yet have the text of that document but we anticipate that it will have a significant impact on hemp-derived […]
Food and Drug Administration (FDA)
Hemp-Derived THC Products: Legal or Loophole?
By Ian A. Stewart, Devon Mills and Neil Willner Hemp-derived CBD products have exploded onto the market since Congress removed hemp from the Controlled Substances Act (CSA) in the 2018 Farm Bill. Now, new hemp-derived products are emerging that contain amounts of THC comparable to state-regulated marijuana consumer products, which are still illegal under federal […]
Hemp CBD: Even Without FDA Regulations, Class Action Suits May Go Forward
by Jesse Mondry, Attorney at Harris Bricken A couple of months ago we reported on a decision in the Southern District of Florida in which the court stayed a putative class action lawsuit against a seller of cannabidiol (CBD) products until the Food and Drug Administration (FDA) completes rulemaking regarding the marketing, including labeling, of […]
Reading the Tea Leaves: Looking at the History of Hemp and CBD to Predict the Future
By Justin Walsh[1] It’s an exciting time to be in hemp and CBD! I have attended and spoken at several conferences over the last year. I have been in places as diverse as Seattle, Denver, Dallas, and Orlando. The products I have seen have made me excited for the future of the industry. I have […]
BREAKING NEWS: FDA and USDA Start Making Sense on Hemp CBD
By Daniel Shortt, Attorney @ Harris Bricken According to Hemp Industry Daily reporter Laura Drotleff, it was an eventful week for hemp regulation at the National Association of State Department of Agriculture (NASDA) meeting in Arlington, Virginia. Drotleff reported on two major developments at NASDA. These developments came from the Food and Drug Administration (FDA) and […]
Using Quality as a Competitive Differentiator in the Cannabis Industry
In the aftermath of the recent vaping epidemic, cannabis consumers and businesses are paying more attention to quality than ever. For the sake of the industry’s long-term growth, let’s hope that concern translates into action with both time and monetary investments in improving and promoting high quality. Today’s savvy cannabis businesses should recognize that focusing […]
Will the FDA’s Ban on E-Cigarettes Affect CBD Vaping Devices?
By Nathalie Bougenies, Attorney at Harris Bricken On January 2, the Food and Drug Administration (“FDA”) issued non-binding guidance (“Guidance”) in which the agency explains how it intends to prioritize enforcement actions to tackle the growing increase in youth use of electronic nicotine delivery systems (“ENDS”)–more commonly and broadly referred to as “e-cigarettes”–as well as to […]
Top 4 Predictions for Hemp and Hemp CBD in 2020
By Griffen Thorne, Attorney at Harris Bricken 2019 was, to put it lightly, an intense year for the hemp and hemp-derived cannabidiol (“Hemp CBD”) industries in the United States. We saw the implementation of the 2018 Farm Bill, strongly worded statements by the Food and Drug Administration (“FDA”) that Hemp CBD was unlawful in many […]
Rebuke: FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns
PRESS RELEASE WASHINGTON–(BUSINESS WIRE)–In response to an alert from the U.S. Food and Drug Administration (FDA), “What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD,” and a news release, “FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details […]
FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns
Press Release Violations include marketing unapproved new human and animal drugs, selling CBD products as dietary supplements, and adding CBD to human, animal foods Today, the U.S. Food and Drug Administration issued warning letters to 15 companies for illegally selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act […]
